Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- LOVE -19.7%, ADBE -11.6%, NDSN -5.8%, CIEN -5.5%, OXM -3.7%
Other news:
- KROS -72.3% (announces update on the phase 2 tropos trial)
- CORT -7% (results from Phase 2 study)
- ORA -4.2% (prices secondary offering of 3.7 mln shares of common stock at $76.20 per share)
- BNED -3.9% (files $40 mln mixed shelf)
- CMTL -3.5% (to delay 10-Q filing)
- CHWY -2.9% (prices offering of 15,852,886 shares of its Class A common stock by selling shareholder)
- NOA -2.9% (awarded contract expected to generate $100 mln in revs)
- KGS -2.4% (announces the underwritten public offering of 5,500,000 shares of its common stock by an affiliate of the funds known as EQT Infrastructure III and EQT Infrastructure IV)
- FISI -2.3% (prices 4.0 mln shares of common stock at $25.00 per share)
- ICFI -1.8% (awarded $40 mln in new contracts)
- ACAD -1.8% (closes sale of Pediatric Disease Priority Review Voucher)
- ACLX -1.7% (provides investor updates in presentation ahead of 66th American Society of Hematology Annual Meeting and Exposition)
- ALNT -1.6% (launches Defense Solutions unit)
- CPA -1.5% (prelim passenger traffic stats for November)
- LDOS -1.3% (awarded $987 mln U.S. Air Force contract)
- EEFT -1.2% (agrees to acquire ATM assets from Swedbank)
- PRQR -1.2% (hosted a virtual analyst and investor event to discuss its proprietary Axiomer ADAR-mediated RNA editing platform)
- AB -1% (prelim AUM for November)
Analyst comments:
- GD -2.5% (downgraded to Sell from Neutral at Goldman)
- KVUE -1.2% (downgraded to Hold from Buy at Deutsche Bank)
- TMUS -1% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)